Ongoing Research on Atopic Dermatitis (AD):
Currently, extensive research is being conducted to improve the understanding, diagnosis, and treatment of this debilitating skin condition.
-
Understanding the Immune Response: AD is associated with immune dysregulation, particularly involving T-helper (Th) cells and cytokines like IL-4, IL-13, and IL-31. Ongoing research is focused on understanding how these immune pathways contribute to skin inflammation and barrier dysfunction in patients with atopic dermatitis. This research is critical for developing new immunomodulatory therapies that can better target the underlying cause of AD.
-
Biomarker Discovery: Scientists are working to identify biomarkers that can be used to predict disease severity, flare-ups, and treatment response. The discovery of reliable biomarkers could help personalize treatment plans and improve patient outcomes. Biomarkers in the form of blood serum, plasma, and skin swabs are being analyzed for their potential to indicate disease activity and progression.
-
Novel Therapeutic Options: The current treatment landscape for AD includes topical corticosteroids, emollients, and immunosuppressants, but newer treatments are being explored. Biologic therapies targeting specific cytokines, such as dupilumab, which blocks IL-4 and IL-13, have shown promise. Research is ongoing to develop additional biologics and small molecule inhibitors that target other immune pathways involved in AD.
-
Genetic Research: Researchers are investigating the genetic predisposition of atopic dermatitis. Studies are examining mutations in genes related to skin barrier function, such as filaggrin and loricrin, which could explain why some individuals are more susceptible to AD. This research could lead to early diagnostic tests and preventative strategies.
-
Microbiome Research: Emerging research highlights the role of the skin microbiome in AD. The presence of bacteria such as Staphylococcus aureus on the skin of AD patients has been linked to worsening inflammation. Research is exploring ways to modulate the microbiome to reduce flare-ups and improve skin health.
An Insight into Atopic Dermatitis Biospecimens We Offer:
Central BioHub is the largest global provider of human biospecimens. In partnership with renowned, certified international biobanks and biorepositories, we serve the research sample needs of biomedical researchers around the world.
For the benefit of dermatology researchers worldwide, Central BioHub offers a wide range of high-quality serum and plasma samples collected from subjects diagnosed with atopic dermatitis and other skin conditions such as contact dermatitis,autoimmune dermatitis,static dermatitis, etc . The skin disease samples are critically analyzed for disease-specific laboratory parameters and stored in our partner's biobank. Moreover, we offer hyper-annotated disease samples with detailed clinical data, medical history, and medication history. Furthermore, Central BioHub, also allows you to reserve and quote for the samples you are interested in through our online marketplace by creating a customer account with us. Hurry up! Make your upcoming dermatitis research project incredible; order atopic dermatitis samples from Central BioHub. Contact us for more information. We are always ready to help you.
Register now for free and find the research specimen that best fits your needs by clicking on Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.